🔎 Trials Near Me

Home › Adenoviridae Infections

Adenoviridae Infections clinical trials recruiting in the U.S.

16 studies for Adenoviridae Infections are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Nov 12, 2026 · NCT01011712

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

RecruitingPhase 1
All ages · All sexes · Updated Nov 4, 2026 · NCT04013802

Viral Infections in Healthy and Immunocompromised Hosts

RecruitingObservational studyHealthy volunteers welcome
6 Months – 120 Years · All sexes · Updated Oct 29, 2026 · NCT01306084

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Oct 23, 2026 · NCT03266627

A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT

RecruitingPhase 3
2 Months · All sexes · Updated Oct 19, 2026 · NCT07387367

A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT07544589

Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT

RecruitingEarly phase 1Healthy volunteers welcome
Ages 1 to 85 · All sexes · Updated Sep 24, 2026 · NCT03665675

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

RecruitingPhase 3
1 Day – 30 Years · All sexes · Updated Sep 11, 2026 · NCT07225972

Donor-Derived Viral Specific T-cells (VSTs)

RecruitingPhase 1/2
4 Weeks · All sexes · Updated Sep 4, 2026 · NCT02048332

Third Party Viral Specific T-cells (VSTs)

RecruitingPhase 2
2 Days · All sexes · Updated Sep 4, 2026 · NCT02532452

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

RecruitingPhase 1
3 Months – 26 Years · All sexes · Updated Jul 30, 2026 · NCT06926894

R-MVST Cells for Treatment of Viral Infections

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05183490

Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Apr 21, 2026 · NCT03878121

Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections

RecruitingPhase 1/2
Up to age 60 · All sexes · Updated May 13, 2025 · NCT04722029

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.